Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Inexperience and massive error in judgement. This was Leo's greatest error and the downside to having an accountant as CEO. Our resources were overestimated and our foes were underestimated.

Why raise money at $4/share when we will soon be on NASDAQ at $12/share? Perhaps they thought there would have been a more favorable partnership born from the B-ABSSSI phase 2b success?

By the time Mako and others struck it likely became apparent that an easy path through phase 3 for B-ABSSSI would not materialize. Fund raising began in the wake of the Rosen suit and so too did the decline in the stock price continue. The rest is history.

We are long past the point where that matters though.

It's time to look forward to the necessary deal which is where our profit will be. The pipeline is worth significantly more than our market cap and so too will the terms of the deal.